By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our
Privacy Policy
for more information.
Accept
Deny
Preferences
Privacy
Privacy Preferences
Essential cookies
Required
Marketing cookies
Essential
Personalization cookies
Essential
Analytics cookies
Essential
Allow all cookies
Reject all cookies
Save preferences
Services
Featured Resource
Blog
Industry Vets Join Together to Help Startups
Regulatory
Clinical
Quality
Speak to an Expert
Industries
Featured Resource
Tools & Templates
Early Phase Oncology Fact Sheet
MedTech
Biotech
Speak to an Expert
Therapeutics
Featured Resource
Case Studies
Dedicated Regulatory Team Takes Charge Of An FDA 510(k) Review
Cardiovascular
Oncology
Pediatrics
Neuromodulation
Orthopedic & Spine
In-Vitro Diagnostics (IVD)
General Surgery
Speak to an Expert
Resources
Featured Resource
Frequently Asked Questions
How can informed consent be obtained from illiterate English-speaking subjects?
Resource Hub
Insights
Tools & Templates
Industry FAQs
Glossary of Terms
Video Hub
Breakthrough Device Designation
Search Our Resource Hub
Company
Featured Resource
Case Study
Dedicated Regulatory Team Takes Charge Of An FDA 510(k) Review
About Proxima
Meet our Experts
Join our Team
Company News & Press
Speak to an Expert
Contact
Contact
Company News & Press
Media, Press, and other Proxima Company Updates
May 2022
Proxima Clinical Research Earns 2022 Great Place to Work® Certification Amid Continued Growth and Promotions
Learn More
May 2022
Kevin Coker: Here's How to Maintain Customer Service, Even When You're Short-Staffed
Learn More
May 2022
Kevin Coker: How to Strategically Plan Your International Business Expansion
Learn More
May 2022
Newsletter: Brains, Bubbles, & BDD | May 9th, 2022
Learn More
April 2022
Proxima Clinical Research Honored by Hermes Creative Awards
Learn More
April 2022
Newsletter: Poison Pills & Contingency Plans | April 26th, 2022
Learn More
April 2022
Proxima Growth 2022: People and Business News in Applied Clinical Trials
Learn More
April 2022
Houston Innovation Map: Houston-based synthetic biology investment fund taps 2 prominent advisers for board
Learn More
April 2022
Newsletter: Twitter, Tesla & Things Not to Do Unless You are a Trillionaire (on a Tuesday no less) | April 12th, 2022
Learn More
April 2022
Kevin Coker: Three Pieces Of Advice For Entrepreneurs Navigating Seed Funding
Learn More
March 2022
Kevin Coker: 15 Leadership Tips For Supporting A Multigenerational Workforce
Learn More
March 2022
Newsletter: RoboPills & Sunscreen Smoothies | March 29th, 2022
Learn More
Previous
Next